Fundación Gecp
Clinical trials sponsored by Fundación Gecp, explained in plain language.
-
New hope for mesothelioma patients: experimental drug shows promise in early trial
Disease control CompletedThis study tested an experimental drug called Bintrafusp alfa (M7824) in 47 people with advanced malignant pleural mesothelioma whose cancer had worsened after platinum-based chemotherapy. The goal was to see if the drug could slow tumor growth and how safe it was. The trial was …
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New drug combo shows promise for tough lung cancer
Disease control CompletedThis study tested a combination of two drugs, atezolizumab and bevacizumab, as the first treatment for people with advanced non-squamous non-small cell lung cancer that has a high number of genetic mutations. The goal was to see if this drug pair could slow down cancer growth. Th…
Phase: PHASE2 • Sponsor: Fundación GECP • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Lung cancer study sheds light on hidden sexual struggles
Knowledge-focused CompletedThis study looked at sexual problems in 553 adults with lung cancer to understand how common and severe they are. Researchers aimed to find patterns that could help doctors provide better support during cancer care. The study did not test any treatments, only gathered information…
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC